Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HYDRASHIFT 2/4 isatuximab

K-Number: K203184 · 2021-11-12

ApplicantSebia
Decision Date2021-11-12
Product CodeCFF
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

HYDRASHIFT 2/4 isatuximab is a medical device manufactured by Sebia. It received FDA 510(k) clearance on 2021-11-12 under approval number K203184. The device is classified under product code CFF. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HYDRASHIFT 2/4 isatuximab?

HYDRASHIFT 2/4 isatuximab is a medical device that received FDA 510(k) clearance on 2021-11-12. It is manufactured by Sebia. The 510(k) number is K203184.

When was HYDRASHIFT 2/4 isatuximab approved by the FDA?

HYDRASHIFT 2/4 isatuximab received FDA 510(k) clearance on 2021-11-12, under approval number K203184.

What company makes HYDRASHIFT 2/4 isatuximab?

HYDRASHIFT 2/4 isatuximab is manufactured by Sebia.

What is the FDA product code for HYDRASHIFT 2/4 isatuximab?

The FDA product code for HYDRASHIFT 2/4 isatuximab is CFF.

Other Devices by Sebia

View all 12 devices →

Related Devices (Code: CFF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.